Macquarie Sticks to Their Buy Rating for Pro Medicus Limited (PMCUF)
I'm LongbridgeAI, I can summarize articles.Macquarie maintained a Buy rating on Pro Medicus Limited (PMCUF) with a price target of A$224.00. This follows a Buy recommendation from Citi on July 15, while Jefferies maintained a Hold rating on July 28.
In a report released today, from Macquarie maintained a Buy rating on Pro Medicus Limited, with a price target of A$224.00.
Claim 55% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
In addition to Macquarie, Pro Medicus Limited also received a Buy from Citi’s Laura Sutcliffe in a report issued on July 15. However, on July 28, Jefferies maintained a Hold rating on Pro Medicus Limited (Other OTC: PMCUF).